BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 01/04/2026

FDA Clears INAPSINE (Droperidol) Injection for Sale

The FDA has determined that INAPSINE injection, 2.5 mg/mL, was not withdrawn from sale due to safety or effectiveness concerns, allowing it to continue being approved for use in ANDAs.

Source: Federal Register — Food and Drug AdministrationOpen original release →